Awareness of lymphedema risk management behaviors and associated factors among breast cancer survivors: Results from a cross-sectional survey

Aim: Breast cancer-related lymphedema (BCRL) is a disabling complication that can develop following breast cancer surgery monthsor even years after treatment ends. The effective management of BCRL requires adhering to simple risk-reduction strategies. Thestudy aim was to assess the awareness and knowledge of lymphedema risk-management behaviors among breast cancer survivorsand identify factors that affect it.Material and Methods: This study was conducted on 250 survivors of breast cancer. Demographic information, treatment details,time since surgery, duration and stage of lymphedema were recorded. Lymphedema education, knowledge about risk-minimizationrecommendations, and information sources were questioned using a survey. A multiple linear regression was used to identifypredictors of lymphedema awareness.Results: Just over half (53.6%) of the patients had adequate lymphedema awareness (score≥8). BCRL was detected in 121 (48.4%)patients. Awareness scores varied by age, education level, body mass index, receiving chemotherapy and radiotherapy, and a previousBCRL treatment (all p

PDF

___

1. Ozmen V. Breast cancer in the world and Turkey. J Breast Health 2008;4:2-5.
2. Stewart BW, Wild C. International Agency for Research on Cancer. World Health Organization. In: World Cancer Report 2014. Geneva: World Health Organization; 2014.
3. Hayes SC, Janda M, Cornish B, et al. Lymphedema after breast cancer: Incidence, risk factors, and effect on upper body function. J Clin Oncol 2008;26;3536- 42.
4. Agrawal S. Late effects of cancer treatment in breast cancer survivors. South Asian J Cancer 2014;3:112-5.
5. Borman P. Lymphedema diagnosis, treatment, and follow-up from the view point of physical medicine and rehabilitation specialists. Turk J Phys Med Rehab 2018;64:179-97.
6. Bakar Y, Berdici B, Sahin N, et al. Lymphedema after breast cancer and its treatment. Eur J Breast Health 2014;10:6-14.
7. Disipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: A systematic review and meta-analysis. Lancet Oncol 2013;14:500-15.
8. Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg 2004;187:69-72.
9. Keast DH, Despatis M, Allen JO, et al. Chronic oedema/ lymphedema:under-recognized and under-treated. Int Wound J 2015;12:328-33.
10. Lee YM, Mak SS, Tse SM, et al. Lymphoedema care of breast cancer patients in a breast care clinic: a survey of knowledge and health practice. Support Care Cancer 2001;9:634-41.
11. Ganz PA, Yip CH, Gralow JR, et al. Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low-middle in-come countries. A Breast Health Global Initiative 2013 consensus statement. Breast 2013;22:606-15.
12. Bani HA, Fasching PA, Lux MM, et al. Lymphedema in breast cancer survivors: As-sessment and information provision in a specialized breast unit. Patient Educ Couns 2007;66:311-8.
13. Bosompra K, Ashikaga T, O’Brien PJ, et al. Knowledge about preventing and managing lymphedema: a survey of recently diagnosed and treated breast cancer patients. Patient Educ Couns 2002;47:155- 163.
14. Sherman KA, Koelmeyer L. The role of information sources and objective risk status on lymphedema riskminimization behaviors in women recently diagnosed with breast cancer. Oncol Nurs Forum 2011;38:27-36.
15. Choi JK, Kim HD, Sim YJ, et al. A Survey of the Status of Awareness of Lymphedema in Breast Cancer Patients in Busan-Gyeongnam, Korea. Ann Rehabil Med 2015;39:609-15.
16. Borman P, Yaman A, Yasrebi S, et al. The Importance of Awareness and Education in Patients with Breast Cancer-Related Lymphedema. J Cancer Educ 2017;32:629-33.
17. Bilodeau BA, Degner LF. Information needs, sources of information, and decisional roles in women with breast cancer. Oncol Nurs Forum 1996;23:691-6.
18. Çal A, Bahar Z. Women’s barriers to prevention of lymphedema after breast surgery and home care needs: a qualitative study. Cancer Nurs 2016;39:17-25.
19. Deng J, Fu MR, Armer JM, et al. Factors associated with reported infection and lymphedema symptoms among individuals with extremity lymphedema. Rehabil Nurs 2015;40:310-9.
20. Kwan ML, Shen L, Munneke JR, et al. Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system. Breast Cancer Res Treat 2012;135:591-602.
21. Fu MR, Chen CM, Haber J, et al. The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors. Ann Surg Oncol 2010;17:1847-53.
22. Herberger K, Blome C, Sandner A, et al. Quality of care of patients with chronic lymphoedema in Germany. Dermatology 2013;226:238-46.
23. Coward, D.D. Lymphedema prevention and management knowledge in women treated for breast cancer. Oncol Nurs Forum 1999;26:1047-53.
24. Morcos BB, Al Ahmad F, Anabtawi I, et al. Lymphedema. A significant health problem for women with breast cancer in Jordan. Saudi Med J 2013;34:62-6.
25. Tam EK, Shen L, Munneke JR, et al. Clinician awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery setting. Breast Cancer Res Treat 2012;131:1029-38.
26. Executive Committee. The Diagnosis and Treatment of Peripheral Lymphedema: 2016 Consensus Document of the International Society of Lymphology. Lymphology. 2016;49:170-84.
27. Lenfödemli hastalar için genel bilgi ve uyarılar. Avaliable at: http://www.lenfodemdernegi.org.tr Access date:11.09.2019
28. Jammallo LS, Miller CL, Singer M, et al. Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer. Breast Cancer Res Treat 2013;142:59-67.
29. Zou L, Liu FH, Shen PP, et al. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study. Breast Cancer 2018;25:309- 14.
30. Ridner SH, Dietrich MS, Stewart BR, et al. Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer 2011;19:853-7.